All Stories

  1. Effectiveness of Treatments for Ocular Toxoplasmosis
  2. The effect of pycnogenol on patients with dysmenorrhea using low-dose oral contraceptives
  3. Combining oral contraceptives with a natural nuclear factor-kappa B inhibitor for the treatment of endometriosis-related pain
  4. Impact of long-acting injectable antipsychotics on medication adherence and clinical, functional, and economic outcomes of schizophrenia
  5. The effect of oral contraceptives on aromatase and Cox-2 expression in the endometrium of patients with idiopathic menorrhagia or adenomyosis
  6. Role of Inflammation and Aromatase Expression in the Eutopic Endometrium and its Relationship with the Development of Endometriosis
  7. Advantages of the association of resveratrol with oral contraceptives for management of endometriosis-related pain
  8. Effect of a hormone-releasing intrauterine system (Mirena®) on aromatase and Cox-2 expression in patients with adenomyosis submitted or not, to endometrial resection
  9. Correlation between aromatase expression in the eutopic endometrium of symptomatic patients and the presence of endometriosis
  10. Activation of NF-κB and COX-2 expression is associated with breakthrough bleeding in patients using oral contraceptives in extended regimens
  11. The effect of a continuous regimen of drospirenone 3 mg/ethinylestradiol 30 μg on Cox-2 and Ki-67 expression in the endometrium
  12. Testosterone replacement therapy in the climacteric: Benefits beyond sexuality
  13. Activation of NF-κB and COX-2 expression is associated with breakthrough bleeding in patients using oral contraceptives in extended regimens
  14. Is aromatase expression in the endometrium the cause of endometriosis and related infertility?
  15. Effect of oral contraceptives on vascular endothelial growth factor, Cox-2 and aromatase expression in the endometrium of uteri affected by myomas and associated pathologies
  16. The effect of oral contraceptives on aromatase expression in the eutopic endometrium of patients with endometriosis
  17. Non-contraceptive health benefits of oral contraceptives
  18. Aromatase expression in the eutopic endometrium of myomatous uteri: The influence of the menstrual cycle and oral contraceptive use
  19. Effect of the menstrual cycle and oral contraceptives on aromatase and cyclooxygenase-2 expression in adenomyosis
  20. P.1.083 A comparison of once-daily venlafaxine XR and paroxetine in depressed outpatients treated in general practise
  21. Evaluation of skin tolerability in patients on a 7-day regimen of a new matrix transdermal estradiol delivery system: an open-label study
  22. Comparative bioavailability study of an once-a-week matrix versus a twice-a-week reservoir transdermal estradiol delivery systems in postmenopausal women
  23. Comparative bioavailability study of a matrix versus a reservoir transdermal estradiol patch in healthy postmenopausal women